| Date Initiated by Firm | December 16, 2019 |
| Create Date | January 16, 2020 |
| Recall Status1 |
Terminated 3 on December 11, 2020 |
| Recall Number | Z-0812-2020 |
| Recall Event ID |
84524 |
| Product Classification |
Multi-analyte controls unassayed - Product Code OHQ
|
| Product | Microbiologics QC Sets and Panels, Gram-Positive Blood Culture Control Panel (Inactivated Pellet), Catalog # 8180
Used in test systems to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. |
| Code Information |
Lot # 8180-46 8180-47 8180-48 8180-49 8180-50 8180-51 8180-52 |
| FEI Number |
2150138
|
Recalling Firm/ Manufacturer |
Microbiologics Inc 200 Cooper Ave N Saint Cloud MN 56303-4440
|
| For Additional Information Contact | Technical Support 320-253-1640 |
Manufacturer Reason for Recall | The recommended hydration fluid for the 8180 Gram-Positive Blood Culture Control Panel (Inactivated Pellet), has changed from sterile 0.85% saline or sterile blood culture media to sterile DI water or pH 7.2 phosphate buffer. |
FDA Determined Cause 2 | Device Design |
| Action | Recall Letters was sent via email to all consignees regarding the correction on 12/16/2019 informing users of a new recommended hydration fluid which is reflected in labeling QC Sets and Panels: Technical Information TIB.2034 Rev G.
Questions can be directed at Technical Support team at 1.320.229.7064 or techsupport@microbiologics.com . A response form is requested to be returned. |
| Quantity in Commerce | 810 |
| Distribution | Distributed nationwide including Washington DC, and distributed internationally to Germany and Netherlands. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|